Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
about
Paired helical filaments from Alzheimer disease brain induce intracellular accumulation of Tau protein in aggresomesIs tau ready for admission to the prion club?Alzheimer's disease pathologic cascades: who comes first, what drives whatTherapeutic and diagnostic challenges for frontotemporal dementiaStructural basis for recognition of the RNA major groove in the tau exon 10 splicing regulatory element by aminoglycoside antibiotics.Targeting mRNA for Alzheimer's and related dementias.Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's diseaseStaging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathyZebrafish models of TauopathyAlzheimer disease models and human neuropathology: similarities and differencesDifferentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.Tau filament formation in transgenic mice expressing P301L tau.Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy.Alternative splicing of exon 10 in the tau gene as a target for treatment of tauopathies.Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17.A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.Specific profile of tau isoforms in argyrophylic grain disease.Differential incorporation of tau isoforms in Alzheimer's disease.The neurodegenerative mitochondriopathies.Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathiesCharacterization of tau oligomeric seeds in progressive supranuclear palsy.Hypoxia alters expression of zebrafish microtubule-associated protein tau (mapta, maptb) gene transcripts.Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration?Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.Increased protein aggregation in Zucker diabetic fatty rat brain: identification of key mechanistic targets and the therapeutic application of hydrogen sulfide.Stable-tau overexpression in human neuroblastoma cells: an open door for explaining neuronal death in tauopathies.Signature tau neuropathology in gray and white matter of corticobasal degenerationMAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tauFrontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis.Silver diagnosis in neuropathology: principles, practice and revised interpretation.The importance of tau phosphorylation for neurodegenerative diseasesCortical Alzheimer type pathology does not influence tau pathology in progressive supranuclear palsy.Corticobasal degeneration: a pathologically distinct 4R tauopathy.Is Huntington's disease a tauopathy?Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer's disease.Prion-like Spreading in Tauopathies.Argyrophilic grain disease is a sporadic 4-repeat tauopathy.Propagation of tau misfolding from the outside to the inside of a cell.
P2860
Q24608787-8A98A45A-268C-4AC4-8581-18195870A7B7Q24630925-719B9228-55F5-45C8-BC56-63EF9E58F8B1Q26995896-6C3FBB30-8F9F-450D-BF63-BCCADC311E6AQ26998919-0984F22F-8942-4268-A215-2BB7561C91D9Q27621003-8ED92A91-0A75-4851-97D6-71BC2FAD500EQ27687153-96777489-18F0-4DEF-BC5B-521494861A5DQ28145739-2ED05128-EB97-4C48-8217-606710767ABCQ28345670-81EB69C6-D4DD-452B-93FB-525BF1F89B9BQ28833507-C51E12AA-5686-4AA1-B68B-7EC4C94257DEQ30499574-E7DD3352-AE27-41F2-83E7-3E12F3FEAAEFQ30588544-94FF3818-CD14-4968-AD4E-8C86F6D4C4F4Q31442641-2BEF01B2-B885-4937-B084-112CE2EA2E42Q33183514-5517A00F-8496-459A-B026-1D3BB1837598Q33393896-4138D3C9-35FD-4BBD-B323-31FA33EC7064Q33750059-87CDC22C-7D73-4730-9B82-DAAB0D68AB07Q33808422-EC148CAE-3B61-4216-875F-79F77A195BFCQ33873537-5D38C2B5-0C78-4E10-82FF-3FE751C31CBEQ33900014-BCFAA7BC-21DB-4F13-AB4A-3B185275427AQ33957065-03AD42F8-71CD-4DB0-9EA6-E31BE5F423B0Q34028511-C6CCD9BB-8458-4BA1-A955-37C13D5E8A54Q34154643-01AF7F51-F167-41D0-8EC7-BF6DA10C423AQ34500234-2A995355-B1EF-495D-97EA-E63DD40BA279Q34537350-245196A2-A5AB-4AFD-A4BC-2677A61D8429Q34989158-90B05F79-1226-4C85-AD20-F53DB5B17FB3Q35005803-593E8561-5A04-46C7-9F28-775AF70E6C36Q35083908-CB302618-5992-43A2-A799-055D54C43FC7Q35700412-FB50D81E-E8E9-478A-9121-8737EBB1AD94Q35747931-B6C466B0-63CA-4022-8411-31E8B553BEE7Q36190981-D8F3F437-DCC7-475B-8C5C-952FDED7B75DQ36465091-04E7C619-E1E4-4FA1-850A-72F6B5D34E66Q36725198-DCE1B23D-96FE-4518-8D27-535B023CEBBAQ36777421-A1645B75-FB8B-44BD-934A-987E57204ADDQ36968220-C58FC9E8-6427-49AA-862B-8A3488895880Q37041779-5D1CE559-4712-4DED-9309-1FAB6B95C6E7Q37864531-AE263A44-8877-4E46-9BBF-C8BF1B809FADQ38771048-F78B625F-3A36-4807-A6E5-C10866F7F2E9Q39005823-81576F42-E557-4EFB-AE09-04F567D8FCA9Q39307688-8A9A9120-0A92-4EC5-8D41-B39242CF43BEQ39527344-0A6DE2C2-61F3-410C-8BFB-E6D3400DCC66Q39873721-312B46E2-6847-47DA-91D9-F4A2E1BA3CE3
P2860
Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@en
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@nl
type
label
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@en
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@nl
prefLabel
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@en
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@nl
P2093
P1476
Neurofibrillary degeneration i ...... xclusively "exon 10" isoforms.
@en
P2093
Delacourte A
Sergeant N
P304
P356
10.1046/J.1471-4159.1999.0721243.X
P407
P577
1999-03-01T00:00:00Z